BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35615451)

  • 1. Integration of Urine Proteomic and Metabolomic Profiling Reveals Novel Insights Into Neuroinflammation in Autism Spectrum Disorder.
    Liu W; Li L; Xia X; Zhou X; Du Y; Yin Z; Wang J
    Front Psychiatry; 2022; 13():780747. PubMed ID: 35615451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of data independent acquisition based proteomic analysis and machine learning to reveal potential biomarkers for autism spectrum disorder.
    Zhang H; Tang X; Feng C; Gao Y; Hong Q; Zhang J; Zhang X; Zheng Q; Lin J; Liu X; Shen L
    J Proteomics; 2023 Apr; 278():104872. PubMed ID: 36898611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of genetic heterogeneity in autism spectrum disorders based on plasma proteomic and metabolomic analysis: multiomics study of autism heterogeneity.
    Tang X; Feng C; Zhao Y; Zhang H; Gao Y; Cao X; Hong Q; Lin J; Zhuang H; Feng Y; Wang H; Shen L
    MedComm (2020); 2023 Oct; 4(5):e380. PubMed ID: 37752942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood Proteomics Analysis Reveals Potential Biomarkers and Convergent Dysregulated Pathways in Autism Spectrum Disorder: A Pilot Study.
    Mesleh A; Ehtewish H; de la Fuente A; Al-Shamari H; Ghazal I; Al-Faraj F; Al-Shaban F; Abdesselem HB; Emara M; Alajez NM; Arredouani A; Decock J; Albagha O; Stanton LW; Abdulla SA; El-Agnaf OMA
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olink proteomics profiling platform reveals non-invasive inflammatory related protein biomarkers in autism spectrum disorder.
    Bao XH; Chen BF; Liu J; Tan YH; Chen S; Zhang F; Lu HS; Li JC
    Front Mol Neurosci; 2023; 16():1185021. PubMed ID: 37293545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic profiling in children with autism spectrum disorder with and without mental regression: preliminary results from a cross-sectional case-control study.
    Rangel-Huerta OD; Gomez-Fernández A; de la Torre-Aguilar MJ; Gil A; Perez-Navero JL; Flores-Rojas K; Martín-Borreguero P; Gil-Campos M
    Metabolomics; 2019 Jun; 15(7):99. PubMed ID: 31250215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A proteomic analysis of urine biomarkers in autism spectrum disorder.
    Wang Y; Zhang J; Song W; Tian X; Liu Y; Wang Y; Ma J; Wang C; Yan G
    J Proteomics; 2021 Jun; 242():104259. PubMed ID: 33957315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary metabolomics of young Italian autistic children supports abnormal tryptophan and purine metabolism.
    Gevi F; Zolla L; Gabriele S; Persico AM
    Mol Autism; 2016; 7():47. PubMed ID: 27904735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Combined Proteomics and Metabolomics Profiling to Investigate the Genetic Heterogeneity of Autistic Children.
    Shen L; Zhang H; Lin J; Gao Y; Chen M; Khan NU; Tang X; Hong Q; Feng C; Zhao Y; Cao X
    Mol Neurobiol; 2022 Jun; 59(6):3529-3545. PubMed ID: 35348996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated genome-wide Alu methylation and transcriptome profiling analyses reveal novel epigenetic regulatory networks associated with autism spectrum disorder.
    Saeliw T; Tangsuwansri C; Thongkorn S; Chonchaiya W; Suphapeetiporn K; Mutirangura A; Tencomnao T; Hu VW; Sarachana T
    Mol Autism; 2018; 9():27. PubMed ID: 29686828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Metabolomics Approach to Screening for Autism Risk in the Children's Autism Metabolome Project.
    Smith AM; Natowicz MR; Braas D; Ludwig MA; Ney DM; Donley ELR; Burrier RE; Amaral DG
    Autism Res; 2020 Aug; 13(8):1270-1285. PubMed ID: 32558271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired lipid metabolism markers to assess the risk of neuroinflammation in autism spectrum disorder.
    Qasem H; Al-Ayadhi L; Bjørklund G; Chirumbolo S; El-Ansary A
    Metab Brain Dis; 2018 Aug; 33(4):1141-1153. PubMed ID: 29569150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiles of urine and blood metabolomics in autism spectrum disorders.
    Likhitweerawong N; Thonusin C; Boonchooduang N; Louthrenoo O; Nookaew I; Chattipakorn N; Chattipakorn SC
    Metab Brain Dis; 2021 Oct; 36(7):1641-1671. PubMed ID: 34338974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic subgrouping and multi-omics analyses reveal reduced diazepam-binding inhibitor (DBI) protein levels in autism spectrum disorder with severe language impairment.
    Pichitpunpong C; Thongkorn S; Kanlayaprasit S; Yuwattana W; Plaingam W; Sangsuthum S; Aizat WM; Baharum SN; Tencomnao T; Hu VW; Sarachana T
    PLoS One; 2019; 14(3):e0214198. PubMed ID: 30921354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomic profiles in Jamaican children with and without autism spectrum disorder.
    Yazdani A; Samms-Vaughan M; Saroukhani S; Bressler J; Hessabi M; Tahanan A; Grove ML; Gangnus T; Putluri V; Mostafa Kamal AH; Putluri N; Loveland KA; Rahbar MH
    ArXiv; 2024 Mar; ():. PubMed ID: 38560734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct Fecal and Plasma Metabolites in Children with Autism Spectrum Disorders and Their Modulation after Microbiota Transfer Therapy.
    Kang DW; Adams JB; Vargason T; Santiago M; Hahn J; Krajmalnik-Brown R
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33087514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic Investigations of Autism Brain Identify Known and Novel Pathogenetic Processes.
    Abraham JR; Szoko N; Barnard J; Rubin RA; Schlatzer D; Lundberg K; Li X; Natowicz MR
    Sci Rep; 2019 Sep; 9(1):13118. PubMed ID: 31511657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers in autism spectrum disorders: Current progress.
    Shen L; Liu X; Zhang H; Lin J; Feng C; Iqbal J
    Clin Chim Acta; 2020 Mar; 502():41-54. PubMed ID: 31857069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary Metabonomic Profiling Discriminates Between Children with Autism and Their Healthy Siblings.
    Liang Y; Xiao Z; Ke X; Yao P; Chen Y; Lin L; Lu J
    Med Sci Monit; 2020 Nov; 26():e926634. PubMed ID: 33237888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomics and Metabolomics Approaches towards a Functional Insight onto AUTISM Spectrum Disorders: Phenotype Stratification and Biomarker Discovery.
    Ristori MV; Mortera SL; Marzano V; Guerrera S; Vernocchi P; Ianiro G; Gardini S; Torre G; Valeri G; Vicari S; Gasbarrini A; Putignani L
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.